Supplements

Multidomain lifestyle interventions combined with pharmacological or nutraceutical approaches may improve cognition in individuals across the Alzheimer's disease continuum.

A systematic review of 12 randomized controlled trials found that combining multidomain lifestyle interventions (2-7 domains including physical exercise, cognitive training, dietary guidance, social activities, sleep hygiene, cardiovascular/metabolic risk management, psychoeducation or stress management) with pharmacological components (e.g., Omega-3, Tramiprosate, vitamin D, BBH-1001, epigallocatechin gallate, Souvenaid, metformin) may effectively improve cognition. Seven trials targeted participants with prodromal AD, MCI, or early dementia, while five focused on at-risk individuals or those with subjective cognitive decline, with two studies enriching populations for APOE-ε4 carriers.

Last updated: Aug 26, 20261 RCTs📖 Read as article →

Evidence Score

Evidence Score42/100
Human RCT★★☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

Study Evidence

Study 1. Risk reduction and precision prevention across the Alzheimer's disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches.

observational

Bereczki E, Mangialasche F, Barbera M, Padilla P, Hara Y, Fillit H, Solomon A, Kivipelto M · The journal of prevention of Alzheimer's disease (2025)

Participants: N/A
Duration: At least 6 months
Intervention: Combination of multidomain lifestyle interventions (≥2 domains) and pharmacological or nutraceutical components (e.g., Omega-3, Tramiprosate, vitamin D, BBH-1001, epigallocatechin gallate, Souvenaid, metformin) for at least 6 months.
Outcome: Cognitive or dementia-related measures (e.g., cognition improvement).
Effect Size: N/A
Population: Individuals across the Alzheimer's disease continuum, including cognitively normal at-risk individuals, those with subjective cognitive decline, mild cognitive impairment, or prodromal AD.

Result:

Mechanism Graph

Multidomain lifestyle interventions target multiple risk factors and disease mechanisms
Pharmacological components add complementary effects
Tailored and early implementation optimizes intervention timing
Result: Potential improvement in cognition

Limitations

  • Only 12 RCTs were identified, limiting generalizability
  • Further refinement of RCT methodology is needed to better align with the multifaceted nature of dementia prevention

Frequently Asked Questions

What types of lifestyle domains were included in the interventions?

The interventions included 2 to 7 lifestyle domains such as physical exercise, cognitive training, dietary guidance, social activities, sleep hygiene, cardiovascular/metabolic risk management, and psychoeducation or stress management.

Which pharmacological components were combined with lifestyle interventions?

Pharmacological components included Omega-3, Tramiprosate, vitamin D, BBH-1001, epigallocatechin gallate, Souvenaid, and metformin.

Who was the target population for these combination trials?

The target population included individuals across the Alzheimer's disease continuum: cognitively normal at-risk individuals, those with subjective cognitive decline, mild cognitive impairment, or prodromal AD.

What was the minimum duration of the interventions in the reviewed trials?

All included interventions lasted at least 6 months.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Bereczki E, Mangialasche F, Barbera M, Padilla P, Hara Y, Fillit H, Solomon A, Kivipelto M. "Risk reduction and precision prevention across the Alzheimer's disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches.." The journal of prevention of Alzheimer's disease, 2025. PMID: 41145344 DOI: 10.1016/j.tjpad.2025.100367
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.